— Know what they know.
Not Investment Advice
Also trades as: ACR.AX (ASX) · $vol 0M

ARUXF OTC

Acrux Limited
1W: +0.0% 1M: +0.0% 3M: -80.5% YTD: -79.7% 1Y: -93.4% 3Y: -89.0% 5Y: -97.5%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 44 · $1.3M mcap · 308M float · 0.0086% daily turnover · Short 71% of daily vol

Balance Sheet Trends

Total Assets
$7M -5.7% ▼
5Y CAGR: -21.8%
Total Liabilities
$5M -13.7% ▼
5Y CAGR: +2.0%
Shareholders Equity
$1M +43.2% ▲
5Y CAGR: -39.8%
Cash & Investments
$2M +97.3% ▲
5Y CAGR: -35.5%
Total Debt
$3M -30.8% ▼
5Y CAGR: +2.4%
Net Debt
$812K -70.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$6M$6M$3M$863K$2M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$6M$6M$3M$863K$2M
Net Receivables$4M$3M$3M$4M$2M
Inventory$0$0$0$0$0
Other Current Assets$0$37K$0$0$0
Total Current Assets$10M$10M$6M$5M$4M
Property, Plant & Equip.$3M$3M$2M$2M$1M
Goodwill & Intangibles$375K$0$0$0$0
Long-Term Investments$3M$0$0$0$0
Other Non-Current Assets-$3M$0$0$0$0
Total Non-Current Assets$4M$3M$3M$2M$3M
Total Assets$14M$13M$9M$7M$7M
— Liabilities —
Accounts Payable$789K$488K$427K$463K$727K
Short-Term Debt$0$0$1M$2M$1M
Deferred Revenue$0$0$0$0$72K
Other Current Liabilities$875K$826K$868K$907K$290K
Total Current Liabilities$3M$2M$4M$4M$3M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$40K$38K$41K$39K$44K
Total Non-Current Liabilities$2M$2M$2M$2M$2M
Total Liabilities$5M$5M$6M$6M$5M
— Equity —
Common Stock$115M$115M$115M$118M$119M
Retained Earnings-$114M-$114M-$120M-$126M-$127M
Accumulated OCI$8M$8M$9M$9M$9M
Total Stockholders Equity$9M$9M$3M$1M$1M
Total Liabilities & Equity$14M$13M$9M$7M$7M
— Key Metrics —
Total Debt$2M$2M$4M$4M$3M
Net Debt-$4M-$4M$759K$3M$812K
Total Investments$3M$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms